Woebot Health, maker of an AI-powered mental health chatbot, sent an email to users announcing it is retiring its app as of June 30.
Woebot's nonprescription digital mental health tool includes content specific to teens, including media literacy, bullying in school settings, and body image and psychoeducation.
According to Behavioral Health Business, members can download their conversation...
A new study from South Korea has demonstrated the use of AI models to possibly diagnose and stratify attention deficit hyperactivity disorder by analysing eye images.
FINDINGS
Researchers from Yonsei University Health System used four machine learning models and the AutoMorph deep learning pipeline to analyse approximately 1,108 retinal fundus photographs from over 600 children with ADHD and...
Research from Japan has demonstrated the use of eye-tracking technology in the early diagnosis of autism spectrum disorder.
Waseda University associate professor Mikimasa Omori set out to examine whether children with potential ASD would exhibit a preference for predictable movement – a behaviour indicative of the neurodevelopmental disorders – longer than typically developing children.
FINDINGS...
Wysa, a company offering an AI-enabled mental health chatbot, announced it is merging with April Health, which integrates virtual behavioral health services into primary care.
Wysa's chatbot guides users through cognitive behavioral therapy for concerns like low mood, stress and anxiety. The company's employer offering also includes a self-care library of exercises to improve self-esteem, sleep...
Coreline Soft announces Australia launch, new FDA approval
South Korean medical imaging AI company Coreline Soft has made its way to Australia after securing a partnership with a major medical device supplier.
It entered into a strategic partnership with ASX-listed ParagonCare, which aims at major hospitals launching lung cancer screening projects as part of the Australian National Lung Cancer...
Boston-based therapeutic extended reality platform XRHealth has acquired virtual reality digital therapeutics company RealizedCare, which combines digital therapeutics with wraparound virtual services to supply value-based chronic care management.
XRHealth offers medical extended reality (XR) experiences focused on the physical and cognitive space, including immersive environments designed to...
A new AI-based tool that gamifies the screening of mild cognitive impairment has been incorporated into a comprehensive health screening service in Singapore.
ReCOGnAIze is a neuroscientific game application developed at the Lee Kong Chian School of Medicine (LKCMedicine) of Nanyang Technology University, Singapore.
WHAT IT'S ABOUT
Powered by a proprietary algorithm, ReCOGnAIze comprises four...
NeuroFlow, a behavioral health technology and analytics company, announced it acquired virtual mental and behavioral health platform Quartet Health in a deal that is expected to close at the end of January.
NeuroFlow’s technology and analytics platform combines behavioral health into physical health workflows while focusing on the "enablement of care delivery and visibility into quality and risk...
The Ministry of Food and Drug Safety in South Korea has approved the first depression diagnosis support AI software-as-a-medical device in the country.
Developed by local AI company Acryl, the product called ACRYL-D01 uses AI to analyse patient interviews to calculate their probability of having depression. It has also been designated as an innovative medical device.
Founded in 2011, Acryl...
Monash University has recently established a new centre for co-designing and developing assistive technology with people with disabilities, focusing on emerging technologies such as AI and robotics.
The Monash Assistive Technology and Society (MATS) Centre, which started in 2023, is led by assistive technology researchers and social scientists from the university's Faculties of Information...
